Jun 30
|
Stifel Keeps Buy rating on Clarivate (CLVT)
|
Jun 27
|
3 of the year’s most notable FDA nods
|
Jun 24
|
Clarivate Secures Major Multi-Year Partnership with Canadian Universities
|
Jun 24
|
OverDrive and Clarivate to Preview Roadmap of Deep Integration for Libby, Kanopy, and Sora with Vega Discover
|
Jun 20
|
DIGITAL HEALTH LEADER JMIR PUBLICATIONS ANNOUNCES ITS 2025 IMPACT FACTOR RESULTS
|
Jun 18
|
Clarivate Unveils the 2025 Journal Citation Reports
|
Jun 16
|
Clarivate Plc (CLVT) To Sponsor ALA Public Supporter Program
|
Jun 16
|
Clarivate Identifies Radioligand Therapy Innovators as Companies to Watch in the Future of Precision Oncology
|
Mar 12
|
Clarivate Reveals Top 100 Global Innovators 2025
|
Mar 7
|
Saurabh Saha Bought 245% More Shares In Clarivate
|
Feb 10
|
Clarivate Recognized for Excellence in Trademark Business in the WTR 1000 2025
|
Oct 4
|
Clarivate in partnership with Abiquifi Announces Annual Summit LATAM Agenda
|
Sep 25
|
Clarivate Unveils Comprehensive Framework to Evaluate the Societal Impact of Research
|
Sep 24
|
New Clarivate Report Reveals Challenges and Trends Shaping IP Operations
|
Sep 23
|
Loss-Making Clarivate Plc (NYSE:CLVT) Expected To Breakeven In The Medium-Term
|
Sep 23
|
Clarivate and Relatable Healthcare Forge Strategic Partnership to Transform Medtech Sales Contracting Process
|
Jul 30
|
Clarivate Introduces New OFF-X ™ Platform for Preclinical and Clinical Safety Intelligence
|
Jul 24
|
Clarivate Director Richard Roedel to Retire from Board of Directors
|
Jul 17
|
Clarivate Plc's (NYSE:CLVT) Intrinsic Value Is Potentially 96% Above Its Share Price
|
Jul 16
|
Clarivate to Report Second Quarter 2024 Results on August 6, 2024
|